A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Clinical trial NCT07743450 · RECRUITING
Trial details
- NCT number
- NCT07743450
- Sponsor
- Ascletis Pharma (China) Co., Limited
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-07-01
- Enrollment
- 1560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.